Inpharmatica, Galapagos discovery deal

Bioinformatics company Inpharmatica (London, U.K.) will use its PharmaCarta chemogenomics technology platform to assess targets from Galapagos (Mechelen, Belgium). Also, Inpharmatica will validate and...